Ethyl Bromo Acetate

Ethyl Bromo Acetate

SCHEMBL30028633

CCOC(=O)CBr.CCOC(=O)CN1C2COCC1CC(C(=O)OCC)C2

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
TRPA1 O75762 1/20 0.44
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 3/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8912207 0.93 MEN1 (0.38) ALDH1A1MEN1KMT2APOLBMAPT
Ethyl Bromo Acetate SCHEMBL30029142 0.88 ALDH1A1 (0.47) ALDH1A1TRPA1MEN1KMT2APOLB
Ethyl Bromo Acetate SCHEMBL30029347 0.86 ALDH1A1 (0.45) ALDH1A1TRPA1MEN1KMT2APOLB
SCHEMBL30028689 0.81 MEN1 (0.43) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL5114769 0.79 MEN1 (0.40) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL8912197 0.78 KMT2A (0.45) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL5121809 0.76 GSK3A (0.40) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL14014876 0.74 MEN1 (0.33) ALDH1A1MEN1KMT2AMAPTTSHR
SCHEMBL8914329 0.71 ALDH1A1 (0.47) ALDH1A1MEN1KMT2APOLBL3MBTL1
SCHEMBL5653075 0.71 ALDH1A1 (0.39) ALDH1A1MEN1KMT2APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022175402-A1 QUINUCLIDINE-3-ONE DERIVATIVES APREA THERAPEUTICS AB (SE) 2022-08-25 WO disclosed